drug · antibody
patient view →cemiplimab
Marketedupdated 2mo agoby $REGN REGENERON PHARMACEUTICALS, INC.🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 8 approved and 25 investigational indications.
indications
investigational
NSCLCMelanoma
targets
Programmed cell death protein 1
all catalysts(17)
approval · 15
phase 1 completion · 1
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that